BUSINESS VENTURE CLINIC
  • Home
  • About
  • Clients
  • Resources
    • Links
    • Videos
  • Blog
  • Contact
    • Clinic Schedule

BLOG POSTS

SAFEs: What are they and when are they used?

12/1/2021

0 Comments

 
SAFEs: What are they and when are they used
Written by: Devan Fafard

A SAFE, short for “Simple Agreement for Future Equity”, is a popular form of early stage outside financing for start-up companies. The SAFE was created in 2013 by YCombinator, the well known start-up incubator, as a quick and easy alternative to convertible notes for seed financing rounds that avoids the quirks of California lending laws.[1] The attractiveness in using a SAFE is, as the name suggests, its simplicity in negotiation and execution. The standard form SAFE document is quite short and, by design, contains few negotiable terms. Another attractive feature is that it piggybacks off of future valuation work by institutional investors, converting into shares of the company in relation to a future priced financing round. This allows a seed investment to be made without undertaking the arduous work of trying to value a company in its infancy.

Negotiable Terms
The terms of a SAFE that are meant to be negotiable, besides the amount of the investment, are the discount rate to the future equity investment that the SAFE will convert at, the financing threshold or “qualified financing” at which the SAFE will convert into equity, and the valuation cap at which the conversion can be priced at.
The discount to the future equity investment may be included to recognize that the SAFE investor invested their funds at an earlier time when the company presumably had a lower valuation. By having the SAFE convert at a discount on a price per share basis to the priced equity financing the SAFE recognizes this time period difference in valuation while still using the valuation work done by the priced equity financing round. The typical discount range is between 10-20%.[2]
The financing threshold provides for the required value of the subsequent equity financing that will automatically trigger the conversion of the SAFE into shares. This sets the minimum financing amount required before the SAFE will convert and the founders will be diluted.
The valuation cap sets the ceiling for the valuation that the SAFEs will convert at during a future equity financing. This term was brought in for SAFE holder protection in response to rapid increases in the value of start-ups.[3] This term functions so that if there is an equity financing at a valuation above the set cap the SAFE will convert as though the financing occurred at the valuation cap amount.[4] This results in the conversion price reflecting the early stage of the SAFE investment and prevents the SAFE investor ownership position being diluted during the subsequent priced financing round past a certain point.

Do SAFEs Make Sense in Canada?
Despite the popularity of SAFE instruments in the start-up community, from an investor perspective they may not be the best financing fit for start-ups in Canada. The SAFE was born as a solution to work around strange lending registration requirements in California.[5] In the absence of these registration requirements in Canada, convertible notes can have longer maturities and provide investors with more downside protection than SAFEs can offer. Canada also lacks the venture capital infrastructure that results in good ideas being subsequently financed and properly valued by sophisticated investors.[6] There is a risk in Canada that either the start-up is not financed at all or is financed and valued by an unsophisticated retail investor who lacks the experience to properly value the venture.[7] Both scenarios are potentially damaging to SAFE investors and indicate that convertible notes may be the better option.
While heralded for their simplicity, it is important to know the pros, cons and mechanics involved in using SAFEs to finance or invest in a start-up business. Seeking out the qualified advice of a legal professional to make sure that a SAFE fits your individual situation is advisable before engaging in this type of seed financing.

Devan Fafard is a member of the BLG Business Venture Clinic and is a 3rd year student at the University of Calgary Faculty of Law   

Footnotes:
[1] Bryce C Tingle, Start-up and Growth Companies in Canada: A Guide to Legal and Business Practice, 3rd ed (LexisNexis Canada, 2018) at 274 [Tingle].
[2] Michael E Reid et al, “Demystifying SAFEs: The good, the bad, and the ugly,” (30 July 2020), online: < https://www.dlapiper.com/en/canada/insights/publications/2020/07/demystifying-safes/> [Demystifying SAFEs].
[3] Tingle, supra note 1 at 273.
[4] Ibid.
[5] Ibid at 274.
[6] Ibid.
[7] Ibid. 
0 Comments



Leave a Reply.

    BVC Blogs

    Blog posts are by students at the Business Venture Clinic. Student bios appear under each post.

    Categories

    All
    ABCA
    Agreements
    Civil Liability
    Confidentiality
    Contractor
    Contracts
    Corporate Governance
    Corporate Structures
    Directors
    Dispute Resolution
    Employee
    Employment Law
    Force Majeur
    Franchise
    Income Tax
    Incorporation
    Indemnification
    Jurisdiction
    Licensing
    Non-Compete
    Patents
    Securities
    Security Interests
    Shareholder Agreement
    Shareholders
    Software
    Startup
    USA
    Warranties

    RSS Feed

    Archives

    April 2025
    March 2025
    February 2025
    December 2024
    November 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    April 2023
    March 2023
    February 2023
    January 2023
    November 2022
    October 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    August 2020
    May 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    May 2018
    April 2018
    March 2018
    February 2018
    November 2017
    October 2017
    August 2017

Terms and Conditions | Privacy Statement
 © 2023 University of Calgary. All rights reserved.
  • Home
  • About
  • Clients
  • Resources
    • Links
    • Videos
  • Blog
  • Contact
    • Clinic Schedule